The Effect of omalizumab in Mastocytosis Patients. Prospective double-blind, placebo-controlled multicentre study

被引：0
|
作者：
Distler, Meike [1 ]
Maul, Julia-Tatjana [1 ]
Steiner, Urs [2 ,3 ]
Jandus, Peter [4 ,5 ]
Murer, Carla [1 ]
Graf, Nicole [6 ]
Petkovic, Tatiana [7 ]
Seebach, Jorg D. [4 ,5 ]
Navarini, Alexander A. [1 ]
French, Lars [1 ]
Helbling, Arthur [6 ]
Schmid-Grendelmeier, Peter [1 ]
机构：
[1] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Immunol, Zurich, Switzerland
[3] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[4] Univ Hosp, Dept Med Specialties, Div Immunol & Allergol, Geneva, Switzerland
[5] Med Fac, Geneva, Switzerland
[6] Graf Biostat, Zurich, Switzerland
[7] ADR AC GmbH Bern, Bern, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2018年 / 148卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SSAIO 10
引用
收藏
页码：5S / 6S
页数：2
相关论文
共 50 条
  • [1] The effect of omalizumab in mastocytosis patients. prospective double-blind, placebo-controlled multicentre study
    Distler, M.
    Maul, J. T.
    Steiner, U. C.
    Jandus, P.
    Graf, N.
    Murer, C.
    Navarini, A. A.
    French, L. E.
    Petkovic, T.
    Seebach, J. D.
    Helbling, A.
    Schmid-Grendelmeier, P.
    ALLERGY, 2018, 73 : 34 - 35
  • [2] The Effect of omalizumab in Mastocytosis Patients. Prospective double-blind, placebo-controlled multicentre study
    Distler, Meike
    Maul, Tatjana
    Steiner, Urs
    Jandus, Peter
    Murer, Carla
    Graf, Nicole
    Petkvic, Tatjana
    Sebach, Joerg
    Navarini, Alexander
    French, Lars
    Helbling, Arthur
    Schmid-Grendelmeier, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB134 - AB134
  • [3] Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients
    Jorg, L.
    Pecaric-Petkovic, T.
    Reichenbach, S.
    Coslovsky, M.
    Stalder, O.
    Pichler, W.
    Hausmann, O.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (02): : 196 - 204
  • [4] Sertraline in dysthymia: A multicentre double-blind placebo-controlled study
    Ravindran, AV
    Wiseman, RL
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 326 - 326
  • [5] A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis
    Carter, Melody C.
    Maric, Irina
    Brittain, Erica H.
    Bai, Yun
    Lumbard, Keith
    Bolan, Hyejeong
    Cantave, Daly
    Scott, Linda M.
    Metcalfe, Dean D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (03) : 1004 - +
  • [6] Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study
    Schrader, E
    Meier, B
    Brattstrom, A
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (03) : 163 - 169
  • [7] Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study
    Grant, Jon E.
    Odlaug, Brian L.
    Potenza, Marc N.
    Hollander, Eric
    Kim, Suck Won
    BRITISH JOURNAL OF PSYCHIATRY, 2010, 197 (04) : 330 - 331
  • [8] The effect of preoperative intravenous use of tenoxicam: A prospective, double-blind, placebo-controlled study
    Akca, T
    Colak, T
    Kanik, A
    Yaylak, F
    Caglikulekci, M
    Aydin, S
    JOURNAL OF INVESTIGATIVE SURGERY, 2004, 17 (06) : 333 - 338
  • [9] Effects of PEMF on Patients With Osteoarthritis: Results of a Prospective, Placebo-Controlled, Double-Blind Study
    Wuschech, Heinz
    von Hehn, Ulrike
    Mikus, Eberhard
    Funk, Richard H.
    BIOELECTROMAGNETICS, 2015, 36 (08) : 576 - 585
  • [10] CANDICIDIN TREATMENT OF PROSTATISM - A PROSPECTIVE DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    JENSEN, KME
    MADSEN, PO
    UROLOGICAL RESEARCH, 1983, 11 (01): : 7 - 10
12345